Oncology NGS Market Forecasts USD 2,193.49 Mn with 15.73% CAGR by 2034 [Yahoo! Finance]
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Yahoo! Finance
Ottawa, April 23, 2025 (GLOBE NEWSWIRE) -- The global oncology NGS market size was valued at USD 508.95 million in 2024 and is predicted to hit around USD 2,193.49 million by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The rising prevalence of cancer and growing genomics research drive the market. North America led the global market owing to advancements in sequencing technologies and the presence of key players. Get All the Details in Our Solutions – View Report Preview @ https://www.towardshealthcare.com/download-brochure/5369 Oncology NGS Market Overview Next-generation sequencing (NGS) is an advanced technique that can sequence millions of DNA fragments in a massively parallel fashion. NGS offers high accuracy, sensitivity, and speed, and can be used to study structural changes and other genetic variations involved in cancer. Due to its high sensitivity, it can detect mutations in even 5% of the DNA isolated from a tumor sample. It
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)? [Yahoo! Finance]Yahoo! Finance
- Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing [Yahoo! Finance]Yahoo! Finance
- Biopharmaceutical Process Analytical Technology Market to Surge: $3.49 Billion by 2030 Predicts Report [Yahoo! Finance]Yahoo! Finance
- Agilent to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Agilent Technologies (NYSE:A) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $165.00 price target on the stock.MarketBeat
A
Earnings
- 11/24/25 - In-Line
A
Sec Filings
- 12/22/25 - Form 10-K
- 12/3/25 - Form 4
- 12/1/25 - Form 4
- A's page on the SEC website